American Freedom Classic 7 (2025) review

Yes, for the right buyer. If you have money you genuinely will not need for 7 years and you want certainty from a carrier with the strongest possible financial strength rating, this is a good product. The no-fee structure, the 10% annual free-withdrawal provision, and the included no-cost waivers are meaningful advantages over MYGA peers that charge for similar features or restrict early access more tightly. It is less appropriate for anyone who might need to tap principal beyond the free amount before the term ends — the surrender charges start at 8% and the MVA adds real exit risk on top of that.

The primary reason to buy American Freedom Classic 7 is certainty: a locked rate for the full term, no market exposure, no crediting complexity, and no ongoing fees eating into the guaranteed return. The secondary reason is carrier quality. MassMutual Ascend is backed by Massachusetts Mutual, one of the few remaining A++ carriers, and that backing is genuinely meaningful for someone who plans to leave a sizable asset in a contract for 7 years. For someone who has already decided on a MYGA and is comparing carriers, the A++ rating combined with competitive rate banding makes this a strong contender.

I think this product is best for conservative accumulation buyers — typically in their 50s or 60s — who have a clear 7-year time horizon, are comfortable with a CD-like commitment, and want to eliminate counterparty risk by staying with a top-rated carrier. It works well for both qualified and non-qualified money. The wider issue-age range (through age 88) also makes it a practical option for older buyers who want a shorter-commitment MYGA alternative is not available. It is a poor fit for anyone without 7-year certainty, anyone who wants income rider access during the term, or anyone who may need to move the funds in a rate environment where the MVA could bite.

You are buying a fixed-rate insurance contract, not a market-linked product. The rate is set at issue, guaranteed for the full 7-year term, and credited to your account value. There is no participation rate, no cap, no index, and no variable component. What you give up is any chance of above-promised returns. What you get is absolute certainty about what you will earn if you hold the contract to term. The MGSV — 87.5% of purchase payments plus interest at 1–3% — is the contractual floor if the worst case happens and the carrier had to liquidate early. The death benefit equals the greater of account value or that MGSV floor.

American Freedom Classic 7 uses a single declared fixed rate that is guaranteed for the entire 7-year term from the contract issue date. The rate is banded by deposit size: contracts below $100,000 credit at a lower rate than contracts at $100,000 or above. As of the Wink data from March 2026, the rates were 4.50% below $100,000 and 4.65% at $100,000 or more — though these are point-in-time snapshots and the rates declared at your contract issue date are what actually matter for your term.

At the end of the 7-year term, you can surrender the contract penalty-free or, if available, renew for another 7-year term at whatever rate is declared at renewal. There is no automatic rollover into a different product type. Additional purchase payments are accepted only during the first 60 days after issue, and each payment carries its own interest crediting terms, so timing matters if you plan to add money.

The most meaningful secondary feature here is the pair of no-cost waivers: the Extended Care Waiver Rider and the Terminal Illness Waiver Rider. Both are included at no charge, and both address a real planning risk — what happens if your health situation forces you to access funds before the term ends. The Extended Care Waiver generally allows penalty-free withdrawals if you require long-term care. The Terminal Illness Waiver provides similar relief for terminal diagnoses. These are not income riders or chronic illness riders in the traditional FIA sense, but for a 7-year MYGA buyer, they serve as a meaningful safety valve. Note that these waivers are not available in Massachusetts, and California uses a modified version tied to facility or home care expenses.

You are making a 7-year commitment when you put money into this contract. The free-withdrawal provision — 10% of purchase payments in year one, 10% of account value in subsequent years — is a meaningful safety valve for normal needs, and RMD-related withdrawals on qualified money should generally not trigger penalties. But anything above the free amount is subject to a surrender charge schedule that starts at 8% and steps down by one percentage point per year:

Beyond the stated charges, this contract includes an MVA — a Market Value Adjustment — which means the actual cost of early exit fluctuates with interest rates. If rates have risen since you bought the contract, the MVA can add to the surrender cost beyond what the schedule shows. If rates have fallen, it can reduce the cost or even work in your favor. The MVA is not unique to this product, but it is a real consideration and should not be treated as negligible. Think of the 7-year commitment as a hard constraint rather than a soft one.

There are no base contract fees and no rider fees on this product. The declared rate is what you earn, period. That is a genuine advantage over some MYGA competitors that layer on administrative charges or charge for waiver features that MassMutual Ascend includes at no cost.

The structural tradeoffs are straightforward: you cannot earn more than the declared rate, the 7-year commitment is long, and the MVA adds a layer of early-exit risk that goes beyond what the surrender charge schedule alone implies. For someone who needs any meaningful chance of liquidity beyond the 10% annual provision before year 7, this contract is the wrong tool regardless of how the rate compares.

Legal Entity: MassMutual Ascend Life Insurance Company

Parent: Massachusetts Mutual Life Insurance Company

AM Best Rating: A++